Andrew Witty
- All
- News
-
England Star's Witty Take On "Leaving The Crease" After Jonny Bairstow Incident in Second Ashes Test
The second Ashes Test between England and Australia will be remembered for the controversial dismissal of Jonny Bairstow by wicketkeeper Alex Carey.
-
Ashes: James Neesham Takes Dig At TV Umpire Over Ben Stokes' No-Ball Controversy In Gabba Test
New Zealand all-rounder James Neesham, who is known for his outspoken and witty posts on social media, has reacted to the controversy over Ben Stokes bowling 14 no-balls in the Gabba Test.
-
GlaxoSmithKline CEO Witty to Retire in March 2017
GlaxoSmithKline said on Thursday its Chief Executive Andrew Witty would retire in 12 months time, after leading the group since 2008, prompting Britain's biggest drugmaker to start a formal search for his successor.
-
United Kingdom Votes in Most Unpredictable Election in Decades
British voters get to decide on Thursday who they want to rule the world's fifth-largest economy in a tight election that could yield weak government, propel the United Kingdom towards a vote on EU membership and stoke Scottish desire for secession.
-
GlaxoSmithKline Appoints RBS's Hampton as Next Chairman
Drug maker GlaxoSmithKline confirmed on Thursday it has chosen Philip Hampton, who currently chairs Royal Bank of Scotland, as its next chairman.
-
China Hands GlaxoSmithKline Record $489 Million Fine
China fined GlaxoSmithKline Plc a record 3 billion yuan ($490 million) on Friday for paying bribes to doctors to use its drugs, underlining the risks of doing business there while also ending a damaging chapter for the British drug maker.
-
GlaxoSmithKline Warns on Profits as Lung Drug Sales Flag
GlaxoSmithKline cut its 2014 earnings outlook after sales fell by a worse-than-expected 13 per cent in the second quarter as its all-important lung drugs struggled in the United States and a strong pound took a bite out of growth.
-
GSK CEO Says Significant Interest in Auction of Mature Drugs
Andrew Witty said he hoped to sell the portfolio of mature drugs, known as established products, by the end of the year.
-
GSK brushes off China probe to post solid 2013 profits
Net profits of GlaxoSmithKline, the British drug maker hit by a bribery probe in China, jumped by a fifth last year as lower taxes offset flat sales.
-
British premier Cameron flies to Beijing, says will push EU-China trade deal
British Prime Minister David Cameron flew into China saying he wanted to lay the ground for a multi-billion-dollar free trade deal between Beijing and the European Union, despite growing unease about his own country's membership of the bloc.
-
GlaxoSmithKline to invest Rs 864 crore in India to set up pharma unit
Global pharmaceutical major GlaxoSmithKline (GSK) on Thursday announced a Rs 864 crore investment in India to set up a medicine manufacturing unit.
-
GlaxoSmithKline staff held in China amid corruption probe: report
At least 18 more people have been detained in China in connection with a corruption scandal involving British drug maker GlaxoSmithKline (GSK), state media reported, giving more details on a probe which has rocked the company.
-
Chief executives and the itch to quit
A handful of recent shock departures by 50-something chief executives at European blue chip companies -- none of them under any obvious pressure to quit -- suggest some of his peers either lack that vigour, or want to channel it elsewhere.
-
England Star's Witty Take On "Leaving The Crease" After Jonny Bairstow Incident in Second Ashes Test
The second Ashes Test between England and Australia will be remembered for the controversial dismissal of Jonny Bairstow by wicketkeeper Alex Carey.
-
Ashes: James Neesham Takes Dig At TV Umpire Over Ben Stokes' No-Ball Controversy In Gabba Test
New Zealand all-rounder James Neesham, who is known for his outspoken and witty posts on social media, has reacted to the controversy over Ben Stokes bowling 14 no-balls in the Gabba Test.
-
GlaxoSmithKline CEO Witty to Retire in March 2017
GlaxoSmithKline said on Thursday its Chief Executive Andrew Witty would retire in 12 months time, after leading the group since 2008, prompting Britain's biggest drugmaker to start a formal search for his successor.
-
United Kingdom Votes in Most Unpredictable Election in Decades
British voters get to decide on Thursday who they want to rule the world's fifth-largest economy in a tight election that could yield weak government, propel the United Kingdom towards a vote on EU membership and stoke Scottish desire for secession.
-
GlaxoSmithKline Appoints RBS's Hampton as Next Chairman
Drug maker GlaxoSmithKline confirmed on Thursday it has chosen Philip Hampton, who currently chairs Royal Bank of Scotland, as its next chairman.
-
China Hands GlaxoSmithKline Record $489 Million Fine
China fined GlaxoSmithKline Plc a record 3 billion yuan ($490 million) on Friday for paying bribes to doctors to use its drugs, underlining the risks of doing business there while also ending a damaging chapter for the British drug maker.
-
GlaxoSmithKline Warns on Profits as Lung Drug Sales Flag
GlaxoSmithKline cut its 2014 earnings outlook after sales fell by a worse-than-expected 13 per cent in the second quarter as its all-important lung drugs struggled in the United States and a strong pound took a bite out of growth.
-
GSK CEO Says Significant Interest in Auction of Mature Drugs
Andrew Witty said he hoped to sell the portfolio of mature drugs, known as established products, by the end of the year.
-
GSK brushes off China probe to post solid 2013 profits
Net profits of GlaxoSmithKline, the British drug maker hit by a bribery probe in China, jumped by a fifth last year as lower taxes offset flat sales.
-
British premier Cameron flies to Beijing, says will push EU-China trade deal
British Prime Minister David Cameron flew into China saying he wanted to lay the ground for a multi-billion-dollar free trade deal between Beijing and the European Union, despite growing unease about his own country's membership of the bloc.
-
GlaxoSmithKline to invest Rs 864 crore in India to set up pharma unit
Global pharmaceutical major GlaxoSmithKline (GSK) on Thursday announced a Rs 864 crore investment in India to set up a medicine manufacturing unit.
-
GlaxoSmithKline staff held in China amid corruption probe: report
At least 18 more people have been detained in China in connection with a corruption scandal involving British drug maker GlaxoSmithKline (GSK), state media reported, giving more details on a probe which has rocked the company.
-
Chief executives and the itch to quit
A handful of recent shock departures by 50-something chief executives at European blue chip companies -- none of them under any obvious pressure to quit -- suggest some of his peers either lack that vigour, or want to channel it elsewhere.
